Tina Roecklein
FDA investigator
Appears on 1 document from 2006, mostly at sites in Pennsylvania. Most often cites control of microbiological contamination (21 CFR 211.113).
- 1
- Documents on file
- 9.0
- Observations per 483
- 2006
- First seen
- 2006
- Most recent
What they cite most
From 27 observations- 21 CFR 211.113Control of microbiological contamination7
- 21 CFR 211.192Production record review5
- 21 CFR 211.160General requirements3
- 21 CFR 211.42Design and construction features3
- 21 CFR 211.110Sampling and testing of in-process materials and drug products2
- 21 CFR 211.166Stability testing2
Activity by year
2006: 1
Where
Pennsylvania 1
Often inspects with
Is Tina Roecklein coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2006-04-28 | 483 Sanofi Pasteur, IncApr 28, 2006 · Swiftwater, Pennsylvania | Swiftwater, Pennsylvania | 9 |
About this profile
What does Tina Roecklein inspect?
Tina Roecklein appears on 1 document on file covering 1 site, mostly in Pennsylvania.
What do they cite most often?
21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.192 and 21 CFR 211.160.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Tina Roecklein is dated Apr 28, 2006.